IQE plc, the Cardiff-headquartered global supplier of advanced compound semiconductor wafers, issued an amended Total Voting Rights announcement on 4 November 2026, correcting the issued share capital figure originally published on 2 November 2026. The company confirmed that as at 31 October 2026, the total number of ordinary shares carrying voting rights stands at 1,331,362,303. The amendment is relevant to shareholders who must calculate notification thresholds under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules. All other details from the original announcement remain unchanged.

Key Points

  • IQE plc (IQE), listed on the AIM market of the London Stock Exchange and headquartered in Cardiff, UK
  • IQE amended its Total Voting Rights announcement to correct the issued share capital figure originally released on 2 November 2026
  • As at 31 October 2026, issued share capital comprises 1,331,366,418 ordinary shares of 1 pence each; 4,115 shares are held in treasury, leaving 1,331,362,303 shares with voting rights
  • Investors should use 1,331,362,303 as the denominator when assessing FCA disclosure obligations under the Transparency Rules

IQE Corrects Issued Share Capital Figure From 2 November 2026 Announcement

IQE plc released an amended Total Voting Rights statement on 4 November 2026, superseding the original RNS (No. 3963B) published at 9:45am on 2 November 2026. The sole change concerns the issued share capital figure. The company confirmed that as at 31 October 2026, its issued share capital consisted of 1,331,366,418 ordinary shares of 1 pence each. With 4,115 of those shares held in treasury and therefore excluded, the corrected voting rights total is 1,331,362,303 ordinary shares. The announcement states that all other details from the original disclosure remain unchanged.

FCA Transparency Rules Denominator for IQE Shareholder Notifications

The practical significance of the amendment lies in its use as a regulatory reference point. Under the FCA's Disclosure Guidance and Transparency Rules, shareholders are required to notify the company when their interest in voting shares crosses certain thresholds. IQE has confirmed that the correct denominator for these calculations is 1,331,362,303. Any shareholder who may have used an incorrect figure from the original 2 November announcement when assessing their disclosure position should review their calculations in light of this corrected total.

IQE's Global Compound Semiconductor Operations Spanning UK, US and Taiwan

IQE describes itself as the leading global supplier of advanced compound semiconductor wafers and materials solutions, with more than 35 years of specialist expertise. The company operates manufacturing facilities across the United Kingdom, the United States, and Taiwan, serving customers from early-stage innovation through to high-volume production. Its technologies support end markets including AI and datacentres, consumer electronics, communications infrastructure, aerospace and defence, and automotive and industrial applications. IQE is headquartered in Cardiff and its shares are admitted to trading on the AIM market of the London Stock Exchange.